TNFSF10 and neoplasm: In addition to revealing a previously unknown facet of the TRAIL system in tumor biology, the discovered link between endogenous TRAIL/TRAIL-R signaling and a tumor-supportive immune microenvironment suggests that inhibiting the interaction of TRAIL with its receptors might serve as an effective therapeutic option to limit the presence of tumor-supportive myeloid cells within the tumor microenvironment.